Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roselli

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Soluble CD40 ligand plasma levels in lung cancerMario Roselli, Tommaso C Mineo, Stefania Basili, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2009
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology GroupPasquale Comella, Vito Lorusso, Luigi Maiorino, et al.
Scandinavian Journal of Gastroenterology|February 4, 2021
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumorsGiovanna Del Vecchio Blanco, Giampiero Palmieri, Diana Giannarelli, et al.
International Journal of Cancer|June 29, 2004
Prognostic value of soluble P-selectin levels in colorectal cancerPatrizia Ferroni, Mario Roselli, Francesca Martini, et al.
Clinical Colorectal Cancer|October 4, 2005
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trialsPasquale Comella, Bruno Massidda, Gianfranco Filippelli, et al.
Journal of Personalized Medicine|February 25, 2023
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and TrastuzumabMarcello Chiocchi, Martina Cerocchi, Federica Di Tosto, et al.
Annals of Palliative Medicine|April 9, 2021
Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and ageVincenzo Formica, Antonella Nardecchia, Cristina Morelli, et al.
Oncotarget|February 9, 2018
Predictive factors for 6 <i>vs</i> 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancerVincenzo Formica, Maria Teresa Ionta, Bruno Massidda, et al.
Biomedicines|September 28, 2024
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized MedicineMaria Cristina Rapanotti, Tonia Cenci, Maria Giovanna Scioli, et al.
Journal of Bone Oncology|August 24, 2019
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trialsAntonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Soluble CD40 ligand plasma levels in lung cancerMario Roselli, Tommaso C Mineo, Stefania Basili, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2009
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology GroupPasquale Comella, Vito Lorusso, Luigi Maiorino, et al.
Scandinavian Journal of Gastroenterology|February 4, 2021
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumorsGiovanna Del Vecchio Blanco, Giampiero Palmieri, Diana Giannarelli, et al.
International Journal of Cancer|June 29, 2004
Prognostic value of soluble P-selectin levels in colorectal cancerPatrizia Ferroni, Mario Roselli, Francesca Martini, et al.
Clinical Colorectal Cancer|October 4, 2005
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trialsPasquale Comella, Bruno Massidda, Gianfranco Filippelli, et al.
Journal of Personalized Medicine|February 25, 2023
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and TrastuzumabMarcello Chiocchi, Martina Cerocchi, Federica Di Tosto, et al.
Annals of Palliative Medicine|April 9, 2021
Health-related quality of life in patients with advanced colorectal cancer: a predictive nomogram including BMI, sex and ageVincenzo Formica, Antonella Nardecchia, Cristina Morelli, et al.
Oncotarget|February 9, 2018
Predictive factors for 6 <i>vs</i> 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancerVincenzo Formica, Maria Teresa Ionta, Bruno Massidda, et al.
Biomedicines|September 28, 2024
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized MedicineMaria Cristina Rapanotti, Tonia Cenci, Maria Giovanna Scioli, et al.
Journal of Bone Oncology|August 24, 2019
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trialsAntonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, et al.
Pageof 17